Role of IL-23 signaling in the progression of premalignant oral lesions to cancer

Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas

(2017) Guoying Zhou et al.   GASTROENTEROLOGY

Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model

(2017) Qiuyang Zhang et al.   PROSTATE

Impact Of Circulating T Helper 1 And 17 Cells in the Blood on Regional Lymph Node Invasion in Colorectal Cancer

(2017) Ji Yeon Lee et al.   Journal of Cancer

HMGB1-TLR4-IL23-IL17A axis promotes paraquat-induced acute lung injury by mediating neutrophil infiltration in mice

(2017) Bailing Yan et al.   Scientific Reports

IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer

(2016) Lei Wang et al.   CANCER RESEARCH

Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer

(2016) M. Rita I. Young et al.   INTERNATIONAL JOURNAL OF CANCER

Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination

(2016) Mahesh Kathania et al.   NATURE IMMUNOLOGY

Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer

(2016) Sara D. Johnson et al.   Frontiers in Immunology

A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)

(2015) Naohiro Yoshida et al.   ANNALS OF SURGICAL ONCOLOGY

Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment

(2015) Kazumasa Mori et al.   BMC CANCER

TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression

(2015) Hou-Pu Liu et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The Therapeutic Potency of HSP65-GTL in GL261 Glioma-bearing Mice

(2015) Youyou Yan et al.   JOURNAL OF IMMUNOTHERAPY

Interleukin-17 potently increases non-small cell lung cancer growth

(2015) LEI WEI et al.   Molecular Medicine Reports

Human ectonucleotidase-expressing CD25highTh17 cells accumulate in breast cancer tumors and exert immunosuppressive functions

(2015) Marion Thibaudin et al.   OncoImmunology

Inflammation and Oxidative Stress Markers and Esophageal Adenocarcinoma Incidence in a Barrett's Esophagus Cohort

(2014) S. Hardikar et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage

(2014) G. L. Stritesky et al.   JOURNAL OF IMMUNOLOGY

Th17 Cells Demonstrate Stable Cytokine Production in a Proallergic Environment

(2014) Nicole L. Glosson-Byers et al.   JOURNAL OF IMMUNOLOGY

Comparative Immune Phenotypic Analysis of Cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in Immune-Competent Individuals: Proportional Representation of CD8+ T-Cells but Not FoxP3+ Regulatory T-Cells Is Associated with Disease Stage

(2014) Andrew Freeman et al.   PLoS One

Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer

(2013) J. Duraiswamy et al.   CANCER RESEARCH

High MUC2 Expression in Ovarian Cancer Is Inversely Associated with the M1/M2 Ratio of Tumor-Associated Macrophages and Patient Survival Time

(2013) Yi-feng He et al.   PLoS One

Administration of a vaccine composed of dendritic cells pulsed with premalignant oral lesion lysate to mice bearing carcinogen-induced premalignant oral lesions stimulates a protective immune response

(2012) Anna-Maria A. De Costa et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck

(2011) Anna-Maria A. De Costa et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

TGFβ1-Induced Inflammation in Premalignant Epidermal Squamous Lesions Requires IL-17

(2010) Javed Mohammed et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY